scholarly journals CD19-Chimeric Antigen Receptor T Cells for Treatment of Chronic Lymphocytic Leukaemia and Acute Lymphoblastic Leukaemia

2015 ◽  
Vol 82 (4) ◽  
pp. 307-319 ◽  
Author(s):  
C. L. Lorentzen ◽  
P. T. Straten
The Lancet ◽  
2020 ◽  
Vol 396 (10266) ◽  
pp. 1885-1894
Author(s):  
Reuben Benjamin ◽  
Charlotte Graham ◽  
Deborah Yallop ◽  
Agnieszka Jozwik ◽  
Oana C Mirci-Danicar ◽  
...  

Author(s):  
Drew Provan ◽  
Trevor Baglin ◽  
Inderjeet Dokal ◽  
Johannes de Vos ◽  
Hassan Al-Sader

Acute myeloblastic leukaemia (AML) - Acute lymphoblastic leukaemia (ALL) - Chronic myeloid leukaemia (CML) - Chronic lymphocytic leukaemia (B-CLL) - Prolymphocytic leukaemia (PLL) - Hairy cell leukaemia and variant - Large granular lymphocyte leukaemia (LGLL) - Adult T-cell leukaemia-lymphoma (ATLL)


Author(s):  
Drew Provan ◽  
Trevor Baglin ◽  
Inderjeet Dokal ◽  
Johannes de Vos

Acute myeloblastic leukaemia (AML) - Acute lymphoblastic leukaemia (ALL) - Chronic myeloid leukaemia (CML) - Chronic lymphocytic leukaemia (B-CLL) - Prolymphocytic leukaemia (PLL) - Hairy cell leukaemia and variant - Large granular lymphocyte leukaemia (LGLL) - Adult T-cell leukaemia-lymphoma (ATLL)


Sign in / Sign up

Export Citation Format

Share Document